Due to crosstalk between the TSC1/TSC2, mTOR, and ELOC pathways, and their overlapping histological and immunohistochemical features, some authors have grouped these tumors under the term “RCC with leiomyomatous stroma”. The gene discussed is MTOR; the disease is renal cell carcinoma.